TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›IBTA›Financials
Annual statements · SEC XBRL · FY2022 – FY2025

Ibotta, Inc. (IBTA) financials

Income statement

Ibotta, Inc. (IBTA) income statement, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$211M$320M$367M$342M
Revenue growth—51.9%14.8%-6.8%
Gross profit$165M$276M$317M$271M
Gross margin78.1%86.3%86.4%79.2%
Operating income-$40.3M$56.0M$27.9M-$841K
Operating margin-19.1%17.5%7.6%-0.2%
Net income-$54.9M$38.1M$68.7M$3.58M
Net margin-26.0%11.9%18.7%1.0%
EPS (diluted)-$6.33$1.42$2.56$0.12

Cash flow

Ibotta, Inc. (IBTA) cash flow, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow-$56.5M$22.7M$116M$95.3M
Capital expenditures$785K$548K$871K$20.3M
Free cash flow-$57.3M$22.2M$115M$75.0M
Share buybacks$25.0K$0.00$31.3M$233M

Balance sheet

Ibotta, Inc. (IBTA) balance sheet, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents$17.8M$62.6M$349M$187M
Total assets—$320M$678M$526M
Total liabilities—$292M$221M$238M
Long-term debt—$64.4M$0.00$0.00
Shareholders' equity-$34.8M$27.9M$457M$288M
Retained earnings—-$209M-$140M-$137M
Shares (wtd avg diluted)8.67M26.9M26.9M30.1M

Every figure is extracted from Ibotta, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Ibotta, Inc.'s annual revenue?
Ibotta, Inc. (IBTA) reported $342M of revenue for fiscal year 2025 — down 6.8% from $367M in FY2024, per its annual report filed with the SEC.
Is Ibotta, Inc. profitable?
Yes — IBTA earned $3.58M of net income in FY2025, a 1.0% net margin, per SEC filings.
What is Ibotta, Inc.'s free cash flow?
$75.0M in FY2025 (operating cash flow $95.3M minus $20.3M of capital expenditures), from the SEC cash-flow statement.
Does IBTA pay a dividend?
Ibotta, Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full IBTA analysis — verdict, score & filings →Is IBTA a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.